vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and TEXAS CAPITAL BANCSHARES INC (TCBI). Click either name above to swap in a different company.
TEXAS CAPITAL BANCSHARES INC is the larger business by last-quarter revenue ($324.0M vs $207.8M, roughly 1.6× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 22.8%, a 34.6% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.
IDYA vs TCBI — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $324.0M |
| Net Profit | $119.2M | $73.8M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | 22.8% |
| Revenue YoY | — | 15.5% |
| Net Profit YoY | 330.1% | 56.8% |
| EPS (diluted) | $1.33 | $1.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $324.0M | ||
| Q4 25 | — | $327.5M | ||
| Q3 25 | $207.8M | $340.4M | ||
| Q2 25 | — | $307.5M | ||
| Q1 25 | — | $280.5M | ||
| Q4 24 | — | $229.6M | ||
| Q3 24 | $0 | $125.3M | ||
| Q2 24 | $0 | $267.0M |
| Q1 26 | — | $73.8M | ||
| Q4 25 | — | $100.7M | ||
| Q3 25 | $119.2M | $105.2M | ||
| Q2 25 | — | $77.3M | ||
| Q1 25 | — | $47.0M | ||
| Q4 24 | — | $71.0M | ||
| Q3 24 | $-51.8M | $-61.3M | ||
| Q2 24 | $-52.8M | $41.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 40.4% | ||
| Q3 25 | 52.2% | 40.5% | ||
| Q2 25 | — | 33.2% | ||
| Q1 25 | — | 21.6% | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | — | -63.8% | ||
| Q2 24 | — | 21.9% |
| Q1 26 | — | 22.8% | ||
| Q4 25 | — | 30.7% | ||
| Q3 25 | 57.4% | 30.9% | ||
| Q2 25 | — | 25.2% | ||
| Q1 25 | — | 16.8% | ||
| Q4 24 | — | 30.9% | ||
| Q3 24 | — | -48.9% | ||
| Q2 24 | — | 15.6% |
| Q1 26 | — | $1.56 | ||
| Q4 25 | — | $2.11 | ||
| Q3 25 | $1.33 | $2.18 | ||
| Q2 25 | — | $1.58 | ||
| Q1 25 | — | $0.92 | ||
| Q4 24 | — | $1.43 | ||
| Q3 24 | $-0.60 | $-1.41 | ||
| Q2 24 | $-0.68 | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | — |
| Total DebtLower is stronger | — | $878.3M |
| Stockholders' EquityBook value | $1.1B | $3.6B |
| Total Assets | $1.2B | $33.5B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $786.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — |
| Q1 26 | — | $878.3M | ||
| Q4 25 | — | $620.6M | ||
| Q3 25 | — | $620.4M | ||
| Q2 25 | — | $620.3M | ||
| Q1 25 | — | $660.5M | ||
| Q4 24 | — | $660.3M | ||
| Q3 24 | — | $660.2M | ||
| Q2 24 | — | $660.0M |
| Q1 26 | — | $3.6B | ||
| Q4 25 | — | $3.6B | ||
| Q3 25 | $1.1B | $3.6B | ||
| Q2 25 | — | $3.5B | ||
| Q1 25 | — | $3.4B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | $1.2B | $3.4B | ||
| Q2 24 | $931.7M | $3.2B |
| Q1 26 | — | $33.5B | ||
| Q4 25 | — | $31.5B | ||
| Q3 25 | $1.2B | $32.5B | ||
| Q2 25 | — | $31.9B | ||
| Q1 25 | — | $31.4B | ||
| Q4 24 | — | $30.7B | ||
| Q3 24 | $1.2B | $31.6B | ||
| Q2 24 | $973.7M | $29.9B |
| Q1 26 | — | 0.24× | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | — |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $360.2M | ||
| Q3 25 | $142.2M | $166.3M | ||
| Q2 25 | — | $63.0M | ||
| Q1 25 | — | $368.0K | ||
| Q4 24 | — | $480.1M | ||
| Q3 24 | $-49.2M | $332.8M | ||
| Q2 24 | $-32.9M | $33.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | $347.6M | ||
| Q3 25 | $142.2M | $161.3M | ||
| Q2 25 | — | $57.5M | ||
| Q1 25 | — | $-2.0M | ||
| Q4 24 | — | $415.2M | ||
| Q3 24 | $-49.7M | $317.6M | ||
| Q2 24 | $-33.9M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 106.1% | ||
| Q3 25 | 68.4% | 47.4% | ||
| Q2 25 | — | 18.7% | ||
| Q1 25 | — | -0.7% | ||
| Q4 24 | — | 180.9% | ||
| Q3 24 | — | 253.4% | ||
| Q2 24 | — | 4.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.8% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 28.2% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 8.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.58× | ||
| Q3 25 | 1.19× | 1.58× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 6.76× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
